FDA Removing Pharmaceutical Representatives From Advisory Panels Authored by Zachary Stieber via The Epoch Times (emphasis ours), The Food and Drug Administration (FDA) is removing pharmaceutical company representatives from advisory committees in a bid to limit industry influence. Dr. Marty Makary, then the nominee to lead the Food and Drug Administration, testifies during a confirmation hearing before the Senate Committee on Health, Education, Labor, and Pensions on Capitol Hill in Washington on March 6, 2025. Madalina Vasiliu/The Epoch Times Dr. Marty Makary, the FDA’s new commissioner, issued a directive that eliminates the role of pharmaceutical representative. “Industry employees are welcome… — Continue at ZeroHedge News : Read More
